Nifty opened at 17104.40 with a gap up of 121 points, the index first rallied further, moved above 17200 and then fell very sharply to reach the opening tick, prices then rallied again more than 100 points and recorded its intraday high at 17213.05 and then fell again, prices then moved down more than 100 points to record its intraday low at 17064.25 , the index again rallied more than 100 points in the last hour of trading and finally closed at 17166.90 near its intraday high with a gain of 183.70 points or 1.08% up. All the sectoral indices closed in green except Pharma , the metal led the bull today and ended with gain of more than 2%.

As the short term trend is down , we should only consider shorting opportunity on an intraday basis, on the daily chart prices have recorded recent swing around 17350 and swing low around 16800, for buying we should wait for a breakout above 17350 or wait for price to consolidate, a dip towards 16800 is also a buying opportunity if price hold its support.  To summarize we should avoid trading the index and wait for the clear sense of direction.


Bank Nifty opened at 35902.90 with a gap up of 302 points , the index rallied further but that rally fizzled out quickly and prices turned down to come close near the opening tick , intraday low was recorded at 35805 and prices again rallied , the index spends the afternoon moving sideways and moved up again in the last hour of trading , the index recorded its intraday high at 36445.35 and finally closed at 36384.80 with a gain of 784 points. Both Private and PSU Banks both have performed well today.

The short term trend is still on the downside and one day rally didn’t affect much of it , however we are expecting a process of consolidation soon and today rally confirmed our expectation. Volatility is still very high intraday trader should look at intraday opportunity  to buy dips if found support and sell rallies if find resistance.


BSE 1651 BUY The stock is on the verge of giving the breakout on the intraday as well as the daily chart. The stock can be bought  with a stop loss of 1615 and for the target of 1700.
NAUKRI 5948 BUY The  immediate trend of the script is bullish. There is a positive  cross over of moving averages  as well as of the indicators therefore  it can be buy above 5965 with a stop loss of 5880 and target  of 6080.


Stock Name Strike Price Buy/Sell CMP Initiation Stop Loss Target Remarks
ICICIBANK 740CE BUY 18 CMP 10 40 OI Increase
Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
RECLTD.Dec 30 134.3 0 0.42 46242000 CIPLA.Dec 30 930.9 -4.56 1.74 10851100
MGL.Dec 30 918.75 0.03 1.05 3528600 DABUR.Dec 30 577.85 -3.19 7.74 10752500
INDIGO.Dec 30 1908.95 0.06 1.3 3919500 PFIZER.Dec 30 5053.95 -2.86 7.79 204000
SHREECEM.Dec 30 26199.45 0.12 0.65 177825 GSPL.Dec 30 305.5 -2.61 6.29 1091400
BALKRISIND.Dec 30 2189.05 0.18 1.86 1722600 MARICO.Dec 30 527.55 -2.31 11.98 8179000
                                                                        Short Covering                                                                       Long Unwinding
ESCORTS.Dec 30 1858.7 0.35 -0.64 5904800 ALKEM.Dec 30 3450 -4.29 -1.93 519000
ICICIGI.Dec 30 1447.95 0.47 -0.2 2768025 METROPOLIS.Dec 30 3155 -4.2 -0.33 603200
ICICIPRULI.Dec 30 599.6 0.71 -0.99 4582500 GLENMARK.Dec 30 503.5 -4.06 -0.11 9403550
LICHSGFIN.Dec 30 377.15 1.28 -1.21 12920000 ABBOTINDIA.Dec 30 18897.3 -1.35 -1.71 27375
BANKNIFTY.Dec 30 36494.85 2 -3.43 2525400 INDIAMART.Dec 30 7375.45 -1.21 -0.18 165600


Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Quantity
Cipla Ltd 928.15 -4.44 3879683 0 31.05 Nifty 50 17166.9 1.08 92283
Glenmark Pharma Ltd 501.45 -4.27 2075911 0 26.03 Nifty Bank 36364.9 1.88 92283
Alkem 3440.9 -4.25 191501 0 60.14 Nifty it 35429 1.1 92283
Metropolis Healthcare Ltd 3156.45 -4.14 444475 0 23.93 India Vix 19.45 -8.14 92283
Pfizer Ltd. 5023.5 -3.33 53856 0 21.04 Nifty Energy 23110.8 1.26 92283
Dabur India Ltd. 576.1 -3.17 3306382 0 63.22 Nifty Fmcg 37457.85 0.19 92280
Gujarat State Petronet 304.8 -2.71 661497 0 28.4 Nifty Mnc 18727.1 1.01 92280
Divis Laboratories Limited 4752.2 -2.59 603122 0 52.48 Nifty Pharma 13442.1 -1.62 92280
Marico Limited 525.05 -2.47 3003218 0 62.99 Nifty Pse 3852.35 0.85 92280
Oracle Fin Serv Soft Ltd 4134.6 -2.38 72456 0 50.82 Nifty Services Sector 24255 1.07 92280


   Domestic                                                                                                                                                  International
INR: Trade Balance (Nov) on 3rd December, 2021

INR: Nikkei Services PMI (Nov) on 3rd December, 2021

•USD: Initial Jobless Claims on 2nd  December, 2021

•USD: Nonfarm Payrolls (Nov) on 3rd December, 2021


  • A possible tightening of monetary policy by the Federal Reserve may not prompt the Reserve Bank of India to follow suit as inflationary pressures are contained for now, a top government adviser said.

  • BSNL has given a timeline of September 2022 for rollout of its 4G services across India, and estimated an incremental revenue of about Rs 900 crore in the first year from such rollout, Parliament was informed on Wednesday. Minister of State for Communications Devusinh Chauhan, in a written reply to the Lok Sabha, made it clear that there is no proposal under consideration for disinvestment of Bharat Sanchar Nigam Ltd (BSNL) and Mahanagar Telephone Nigam Ltd (MTNL).

  • Tata Power Company on Wednesday said that its wholly owned subsidiary Tata Power Solar Systems has received Letter of Award (LoA) from Solar Energy Corporation of India (SECI). The contract involves building 100 MW EPC solar project along with 120 MWh utility scale battery energy storage system (BESS). The total contract value of the project is approximately Rs 945 crore. The project will be executed within 18 months.

  • Biocon said on Wednesday that it has been selected for the Dow Jones Sustainability Index (DJSI) in the Emerging Markets (EM) category for its Environmental, Social and Governance (ESG) practices. The pharma major made a formal submission for Corporate Sustainability Assessment for its listing on the DJSI for the first time this year and made it to the DJSI EM Index with a total sustainability score of 45 as against an industry average of 18, achieving a 93rd percentile position.

Source: Economic Times,  Indian Express  ,Business Today, Livemint, Business Standard, Bloomberg Quint


Company Name Purpose Ex-Date Company Name Purpose Ex-Date
ANMOL General 02-Dec-21 NMDC Interim Dividend 03-Dec-21
CGPOWER General 02-Dec-21 SDC Half Yearly Results 03-Dec-21
JUBLINGREA General 02-Dec-21 SHARP Quarterly Results 03-Dec-21
MADHAVIPL General 02-Dec-21 STDSFAC General 03-Dec-21
NOVIS A.G.M.;Audited Results 02-Dec-21 TARMAT Preferential Issue of shares 03-Dec-21
PACL Stock  Split 02-Dec-21 VICEROY General;A.G.M. 03-Dec-21
PATINTLOG General;Rights Issue 02-Dec-21 YASHRAJC General 03-Dec-21
TOYAMIND General 02-Dec-21 ZSOUTGAS General 03-Dec-21
XPROINDIA General 02-Dec-21 CHEVIOT Buy Back of Shares 04-Dec-21
GVKPIL Quarterly Results 03-Dec-21 GSS General 04-Dec-21
ISTRNETWK General 03-Dec-21 SAYAJIHOTL Scheme of Arrangement 04-Dec-21
JJEXPO A.G.M.;Audited Results 03-Dec-21 SETCO A.G.M.;Quarterly Results 04-Dec-21
JPTRLES General 03-Dec-21 TIRUFIN Employees Stock Option Plan;General 04-Dec-21
MRPL General 03-Dec-21 EQUIPPP A.G.M. 05-Dec-21


Company Name Ex-Date Purpose Company Name Ex-Date Purpose
APOLLOPIPES 02-Dec-21 Bonus issue 2:1 COALINDIA 06-Dec-21 Interim Dividend – Rs. – 9.0000
BAJAJST 02-Dec-21 Final Dividend – Rs. – 3.0000 PANCHSHEEL 06-Dec-21 Bonus issue 1:1
GRATEXI 02-Dec-21 E.G.M. CHLOGIST 07-Dec-21 E.G.M.
NCLRESE 02-Dec-21 Bonus issue 1:1 GPL 08-Dec-21 Amalgamation
NCLRESE 02-Dec-21 Stock  Split From Rs.2/- to Rs.1/- BNKCAP 09-Dec-21 Dividend – Rs. – 2.5000
NOVAPUB 02-Dec-21 E.G.M. DUGARHOU 09-Dec-21 E.G.M.
IEX 03-Dec-21 Bonus issue 2:1 OAL 09-Dec-21 Interim Dividend – Rs. – 1.5000


Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL